Novavax, Inc. (NASDAQ: NVAX) is 109.79% higher on its value in year-to-date trading and has touched a low of $3.53 and a high of $23.86 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The NVAX stock was last observed hovering at around $10.25 in the last trading session, with the day’s loss setting it -0.18%.
Currently trading at $10.07, the stock is -13.57% and -16.72% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.47 million and changing -1.76% at the moment leaves the stock 3.58% off its SMA200. NVAX registered 58.58% gain for a year compared to 6-month gain of 132.56%. The firm has a 50-day simple moving average (SMA 50) of $12.0916 and a 200-day simple moving average (SMA200) of $9.72225.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -20.27% loss in the last 1 month and extending the period to 3 months gives it a -21.39%, and is -0.49% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.18% over the week and 7.20% over the month.
Novavax, Inc. (NVAX) has around 1543 employees, a market worth around $1.61B and $987.67M in sales. Fwd P/E is 283.02. Profit margin for the company is -29.80%. Distance from 52-week low is 185.08% and -57.80% from its 52-week high.
with sales reaching $65.77M over the same period.The EPS is expected to grow by 81.38% this year, but quarterly earnings will post -22.60% year-over-year. Quarterly sales are estimated to shrink -64.80% in year-over-year returns.
Novavax, Inc. (NVAX) Top Institutional Holders
306.0 institutions hold shares in Novavax, Inc. (NVAX), with institutional investors hold 56.67% of the company’s shares. The shares outstanding are 160.09M, and float is at 153.03M with Short Float at 23.34%. Institutions hold 54.19% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 14.08 million shares valued at $178.19 million. The investor’s holdings represent 10.0599% of the NVAX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.85 million shares valued at $149.98 million to account for 8.4669 of the shares outstanding. The other top investors are SHAH CAPITAL MANAGEMENT which holds 9.66 million shares representing 6.9056% and valued at over $122.32 million, while D. E. SHAW & CO., INC. holds 4.5185 of the shares totaling 6.32 million with a market value of $80.04 million.
Novavax, Inc. (NVAX) Insider Activity
#####
Novavax, Inc. disclosed in a document filed with the SEC on Jun 21 ’24 that YOUNG JAMES F (Director) sold a total of 7,500 shares of the company’s common stock. The trade occurred on Jun 21 ’24 and was made at $14.09 per share for $0.11 million. Following the transaction, the insider now directly holds 61760.0 shares of the NVAX stock.
Still, SEC filings show that on Jun 18 ’24, YOUNG JAMES F (Director) disposed off 7,500 shares at an average price of $13.72 for $0.1 million. The insider now directly holds 69,260 shares of Novavax, Inc. (NVAX).
